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CD14 is a glycosylphosphatidylinositol (GPI)-anchored receptor known to serve as a
co-receptor for several Toll-like Receptors (TLRs) both at the cell surface and in the
endosomal compartment. CD14 can be expressed by cells of both hematopoietic and
non-hematopoietic origin as a cell membrane or secreted protein. Although CD14 was
discovered more than 20 years ago, its activities remain largely to be defined. Most of
the information available concerns CD14’s role as a co-receptor working with TLR4 and
facilitating cellular responses to low doses of lipopolysaccharide (LPS). Recent studies
have highlighted and molecularly defined many other functions of this pattern recognition
receptor (PRR). These functions include the mechanisms through which CD14 allows the
activation of the TLR4-TRAM-TRIF pathway upon LPS stimulation; the capacity of CD14
to transduce a TLR4-independent signaling pathway leading to the activation of NFAT
transcription factor family members with important consequences in myeloid cells; the
CD14 influence on cell metabolism in conditions predisposing to obesity. In this review,
we summarize recent progresses toward the molecular definition of the multiple roles
exerted by CD14 in innate immune cells in response to LPS and the consequences of
CD14 activation in physiologic and pathologic conditions.
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INTRODUCTION
The innate immune system has evolved to sense and respond to
a wide range of microorganisms. Microbial detection is medi-
ated by specialized receptors called pattern-recognition receptors
(PRRs), which are able to recognize microbe-associated molecu-
lar patterns (PAMPs).
PRRs are widely expressed on cells that serve as sentinels of the
immune system such as dendritic cells (DCs) and macrophages.
After PAMP recognition, PRRs transduce a signal inside the cells
leading to transcription factor activation. Activated transcription
factors contribute to the initiation of the inflammatory process
and induce the maturation of antigen-presenting cells (APCs)
involving the upregulation of cell surface and soluble molecules.
Thanks to the maturation process, APCs acquire the ability to
activate adaptive immunity (Joffre et al., 2009).
Toll-like receptor 4 (TLR4) was the first PRR discovered to be
expressed by mammalian innate immune cells (Medzhitov and
Janeway, 1997; Medzhitov et al., 1997). After TLR4, 13 new TLRs
have been discovered together with additional classes of PRRs,
including CLRs (C-type lectin-like receptors), RLRs (RIG-I-like
receptors), and NLRs (NOD-like receptors) (Kawai and Akira,
2011).
TLRs are among the best characterized PRRs and are key regu-
lators of anti-bacterial and anti-viral immune responses (Janeway
andMedzhitov, 2002). After activation, different adaptor proteins
containing the Toll-interleukin (IL)-1 receptor (TIR) domain are
recruited to bind to the TIR domains of TLRs. There are four
main known adaptor proteins that interact with TLRs: MyD88,
TIRAP, TRAM, and TRIF. Through these adaptors, TLRs can
activate downstream kinases, including IL-1 receptor-associated
kinases (IRAK) (Kawagoe et al., 2007, 2008), mitogen-activated
protein (MAP) kinases, and a group of E3 ubiquitin ligases, TRAF
(Hacker et al., 2006). The result of this process is a complex
regulation of gene transcription mediated by the activation of
transcription factors such as NF-kB, AP-1, and IRFs (Medzhitov
and Horng, 2009).
Before the discovery of TLR4, CD14—first identified as a
marker of monocytes (Goyert et al., 1986)—was proposed to be
a PRR (Pugin et al., 1994). It was thought to signal intracel-
lular responses after the recognition of a vast array of bacterial
products, including lipopolysaccharide (LPS) (Pugin et al., 1994).
CD14 is a 55 kDa glycoprotein expressed on the surface of
myelomonocytic cells as a glycosylphosphatidylinositol (GPI)-
anchored receptor or can be secreted in a soluble form (Ulevitch
and Tobias, 1995). It seemed, therefore, improbable it could have
signaling capacities given the absence of an intracellular tail.
For a long time, efforts have concentrated on defining its role
as the TLR4 and TLR1/2 co-receptor and more recently as the
co-receptor of other TLRs, including TLR3, 6, 7, and 9 (Akashi-
Takamura and Miyake, 2008; Baumann et al., 2010; Weber et al.,
2012).
Recent advances in CD14 biology have confirmed its role not
only as the TLR co-receptor but also as a PRR (Zanoni et al., 2009,
2011). Moreover, in addition to the functions in innate immunity
(Ostuni et al., 2010), a more general role for CD14 in regulating
metabolism, insulin resistance, and obesity is emerging (Johnson
et al., 2004; Roncon-Albuquerque et al., 2008; Fernandez-Real
et al., 2011). The purpose of this mini-review is to give an
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overview of the recent progress on the definition of the multiple
roles exerted by CD14 in response to LPS and microbial infec-
tions. The influence of this PRR on cell metabolism in conditions
predisposing to obesity will also be considered.
CD14 AND THE LPS RECEPTOR COMPLEX
LPS is the major component of the outer membrane of Gram-
negative bacteria. LPS consists of lipid A, a core polysaccha-
ride, and an O-polysaccharide chain of variable length (often
more than 50 monosaccharide units). Colony morphology
(“smooth” vs. “rough”) is indicative of the O-glycosylation sta-
tus. Microbial variants with long O-polysaccharide chains form
smooth colonies, whereas those that have short, truncated,
O-polysaccharide chains form rough colonies (Kelly et al., 1991).
CD14, together with TLR4 and MD-2, forms the multi-
receptor complex that recognizes LPS on the cell membrane
(Miyake et al., 2000; Triantafilou and Triantafilou, 2002). The
structures of mouse and human CD14 have been crystallo-
graphically solved. Human and mouse CD14 are very similar
and show the horseshoe-like structure typical of leucine-rich-
repeat-containing proteins with a hydrophobic pocket at the
NH2-terminal side. This pocket has a cluster of positively
charged residues at the rim that presumably accommodates
acylated ligands like the phosphorylated lipid A moiety (Kim
et al., 2005; Kelley et al., 2013). However, while mouse CD14
crystallizes as a dimer only, human CD14 crystallizes as a
monomer. Compared with mouse CD14, human CD14 contains
an expanded N-terminal pocket and different rim residues that
are likely to be important for ligand binding and cell activa-
tion, although the significance of these differences remains to
be determined (Kelley et al., 2013). Moreover, since CD14 can
also bind the carbohydrate portion of LPS (Pugin et al., 1994),
it has been proposed that additional hydrophilic regions span-
ning outside the N-terminal pocket but in close proximity to it
can contribute to LPS binding (Kim et al., 2005). This flexible
CD14 structure could explain why CD14 is capable of binding
different LPS species with similar affinity and also, perhaps, the
promiscuity of this PRR, which serves as a co-receptor for TLR1,
2, 3, 4, 6, 7, and 9, contributing to ligand recognition (Akashi-
Takamura and Miyake, 2008; Baumann et al., 2010; Weber et al.,
2012).
The first role described for CD14 in LPS recognition was
the enhancement of the sensitivity of innate immune cells to
this inflammatory stimulus. CD14 is capable of binding LPS at
picomolar concentrations and presenting and transferring it to
the TLR4-MD2 complex for the initiation of the transduction
pathway (Gioannini et al., 2004). CD14-deficient macrophages
display a markedly reduced sensitivity to low concentrations of
LPS compared to wild-type cells (Perera et al., 1997). Moreover,
CD14-deficient mice do not develop septic shock after LPS
or Gram-negative bacterial exposure, while wild-type mice do
(Haziot et al., 1996).
TLR4 is unique because it engages all four adaptors—TIRAP,
MyD88, TRAM and TRIF—and thus is the only TLR capable of
activating both the TIRAP-MyD88-dependent pathway and the
TRAM-TRIF-dependent pathway leading to the secretion of type-
I interferons (IFNs) (Akira and Hoshino, 2003).
In the presence of LPS, CD14 and TLR4-MD2 are brought in
close proximity (da Silva Correia et al., 2001) inside lipid rafts
(Schmitz and Orso, 2002). After translocation into the lipid rafts,
TLR4 in the plasma membrane activates the TIRAP-MyD88-
dependent pathway, which leads to the first wave of NF-kB
activation (Kawai et al., 2001). Subsequently, the entire recep-
tor complex, including CD14, is internalized (Zanoni et al., 2011)
and redirected to the endosomal compartment. The activation of
the TRAM-TRIF pathway starts from the endosome (Kagan et al.,
2008).
Jiang and colleagues (Jiang et al., 2005) have demonstrated that
CD14 is absolutely required for LPS-induced activation of the
TLR4/TRAM-TRIF pathway even at very high LPS doses, when
CD14 is dispensable for LPS recognition by the TLR4-MD2 com-
plex. In the absence of CD14, both smooth and rough LPS cannot
induce TRAM-TRIF-dependent IRF3 activation and subsequent
type-I IFN production.
We have recently found that CD14 is capable of control-
ling the entire LPS receptor complex endosomal re-localization,
therefore explaining why type-I IFN production is CD14 depen-
dent (Zanoni et al., 2011). ITAM-bearing molecules, the tyro-
sine kinase Syk, and its downstream effector phospholipase Cγ2
(PLCγ2) have also been identified as important regulators of
the CD14-mediated TLR4 endosomal re-localization (Figure 1)
(Zanoni et al., 2011). CD14 is dispensable for type-I IFN produc-
tion only if LPS can directly reach the endosomal compartment
FIGURE 1 | CD14 has three fundamental functions. Panel 1, CD14 favors
optimal NF-kB-dependent cytokine production by allowing the recognition of
low-LPS doses. Panel 2, CD14 promotes TLR4 endocytosis and type-I IFN
expression. Panel 3, CD14 has autonomous signaling functions leading to
the activation of NFATc transcription factor family members. The
consequences of NFAT activation are mostly unknown.
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through an endocytic process independent of TLR4 recognition,
for instance when it is administered with liposome combinations
(Watanabe et al., 2013) or associated with microbeads (Zanoni
et al., 2011).
Based on these observations it emerges that CD14 plays a
crucial role in regulating cellular responses to LPS by: (i) con-
trolling LPS presentation to TLR4 with a consequent facilitation
of cellular responses to low LPS doses; and (ii) controlling the
re-localization of the LPS receptor complex to the endosome, irre-
spective of the LPS concentration, with the consequent activation
of the TRAM-TRIF pathway and type-I IFN production. These
two pathways are depicted in Figure 1.
CD14 SIGNALING CAPACITIES
In addition to controlling the TRIF-dependent pathway, CD14
has TLR4-independent signal transduction capacities in myeloid
cells, such as DCs (Zanoni et al., 2009). Following LPS stimula-
tion, CD14 leads to src family kinase (SFK) and PLCγ2 activa-
tion. PLCγ2, in turn, hydrolyzes membrane phosphatidylinositol
bisphosphate (PIP2) generating inositol-triphosphate (IP3) and
dyacylglycerol (DAG) (Zanoni et al., 2009). This leads to an
increase in intracellular Ca2+ concentration and the activation
of the phosphatase Calcineurin. Cytoplasmic NFAT transcrip-
tion factors are, consequently, dephosphorylated and can migrate
to the nucleus (Zanoni et al., 2009). This process is depicted in
Figure 1.
It remains unclear how CD14 can transduce this signaling
pathway and, in particular, whether CD14 induces Ca2+ fluxes
directly or indirectly. There are two possibilities: (i) CD14 directly
induces Ca2+ mobilization by recruiting SFKs at the lipid rafts
and inducing their activation; or (ii) CD14 presents LPS to an
unknown protein (by analogy with LPS presentation to TLR4),
which in turn activates the calcium pathway. Although the second
hypothesis cannot be formally excluded, indirect evidence favors
the first one.Moreover, a direct role in Ca2+mobilization through
interactions with lipid rafts and SFK activation has been demon-
strated for other GPI-anchored receptors, such as CD59 (Suzuki
et al., 2007a,b). Understanding these details of the CD14 signal-
ing capacity would contribute to answering, at least in part, the
old question of how GPI-anchored receptors initiate a signaling
pathway.
The NFATc proteins were originally identified as transcription
factors capable of regulating IL-2 production in T cells (Shaw
et al., 1988). Since then, different NFATc functions in adaptive
immunity have been identified, including roles in T- and B-cell
differentiation and activation (Wu et al., 2007). In innate immune
cells, little is known about the NFATc family role, although there
is substantial evidence that the NFATc signaling pathway can be
activated in physiological and pathological conditions (Zanoni
and Granucci, 2012).
At the moment, few but important biological processes regu-
lated by the CD14-NFAT pathway have been described in LPS-
activated DCs and include regulation of IL-2 (Granucci et al.,
2001) and prostaglandin (PG) E2 (PGE2) (Zanoni et al., 2012)
production and the induction of a proapoptotic pathway in ter-
minally differentiated DCs (Goodridge et al., 2007; Zanoni et al.,
2009).
In the context of LPS-mediated inflammatory conditions, DC-
derived IL-2, produced in a CD14-dependent manner, is one of
the cytokines required, at least in the mouse system, to elicit
IFN-γ production from NK cells (Granucci et al., 2004). IFN-γ
potently activates macrophages and favors Th1-lineage commit-
ment of CD4+ T cells. As such, it comes as no surprise that early
IFN-γ release by NK cells is crucial for controlling a variety of
bacterial infections, including E. coli, while adaptive immunity
is being primed (Dunn and North, 1991; Ferlazzo et al., 2003;
Newman and Riley, 2007; Lapaque et al., 2009; Pontiroli et al.,
2012).
The role of PGE2 produced in a CD14-dependent man-
ner during LPS-mediated inflammatory conditions has also
been widely investigated. Prostanoids, such as PGE2, contribute
to the generation of local edema formation by controlling
vasodilation (Legler et al., 2010). It has emerged that DCs
are the major regulators of edema formation induced in vivo
by LPS administration, and they exert this function thanks
to their capacity to activate the CD14-NFAT pathway (Zanoni
et al., 2012). In particular, the NFATc transcription factor fam-
ily controls the transcription of Ptges1 that encodes a pro-
tein called microsomal PGE synthase 1 (mPGES-1). mPGES-1,
together with phospholipase A2 (cPLA2α) and cyclooxygenase-
2 (COX-2), regulates PGE2 synthesis and release. PGE2 in
turn favors local swelling formation (Zanoni and Granucci,
2012).
ROLE OF CD14 IN HOST DEFENSE
The role of CD14 during microbial infections remains largely
to be defined, despite the progress in the definition of CD14
functions as a TLR co-receptor and PRR.
The CD14 involvement in host defense against viral and bac-
terial infections has been investigated in several experimental
models with opposing results. An essential protective role of
CD14 has been established in some forms of intestinal infections,
while positive and negative effects have been described in pul-
monary infections depending on the infectious agent. A globally
detrimental role for CD14 has, finally, been shown in systemic
infections.
CD14 has proved to be required for host defense in two models
of Gram-negative, clinically relevant, respiratory pathogens, i.e.,
Haemophilus influenzae and Acinectobacter baumanii (Wieland
et al., 2005; Knapp et al., 2006). In both cases, CD14 was required
for bacterial clearance but not for the establishment of the inflam-
matory process that required, instead, TLR4. Analogously, CD14
has proved to be essential for bacterial clearance in a rabbit model
of E. coli-induced pneumonia. Also in this case, no effect on neu-
trophil infiltration and cytokine production has been described
in CD14-deficient conditions (Frevert et al., 2000). A detri-
mental role of CD14 has been defined in the responses against
Streptococcus pneumoniae (Dessing et al., 2007), a Gram-positive
bacterium causing pneumonia, and Burkholederia pseudomallei, a
Gram-negative bacterium causing melioidosis (Wiersinga et al.,
2008). CD14-deficient mice, unlike wild-type mice, were pro-
tected from severe lung inflammation, bacterial outgrowth, and
sepsis induced by intranasal bacterial instillation (Wiersinga et al.,
2008).
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In models of gut infection, rabbits treated with a neutralizing
anti-CD14 antibody exhibited a remarkably higher susceptibil-
ity to infections with Shigella, the cause of bacillary dysentery
(Wenneras et al., 2001). More severe tissue damage and a strong
increase in bacterial intestinal mucosa invasion were observed in
CD14-impaired rabbits, while the local inflammatory process was
similar in antibody-treated and untreated animals.
Concerning systemic infections, CD14-deficient mice were
resistant to septic shock induced by intraperitoneal or endove-
nous E. coli administration (Haziot et al., 1996), and showed a
much better control of bacterial spread compared to wild-type
animals. Further studies have demonstrated that timing and effi-
ciency of peritoneal neutrophil recruitment in mutant animals
accounted for reduced bacteremia (Haziot et al., 2001).
In conclusion, the contribution of CD14 to infection con-
trol may be either positive or negative depending both on the
microorganism and the site of infection. The regional influence
exerted by CD14 would support the hypothesis proposed some
years ago that CD14 expression by non-hematopoietic cells could
influence innate immune functions (Jersmann, 2005). It would
be interesting to understand the functions of CD14 in non-
hematopoietic cells to better appreciate its regulatory activities in
re-establishing homeostatic conditions.
ROLE OF CD14 IN METABOLISM
In addition to playing a role in host defense, PRRs have
been recently appreciated for their role in metabolism regula-
tion (Konner and Bruning, 2011; Tannahill and O’Neill, 2011).
Although, at the moment, the connection between these two
functions is only partially understood (Tannahill and O’Neill,
2011), a link could be represented by the general necessity to
restore homeostasis after tissue damage caused either by infection
or obesity, or various kinds of endogenous signals.
Concerning CD14, an intriguingly negative contribution in
the regulation of the body plan has been observed (Johnson
et al., 2004). CD14-deficient mice have an ideal body plan with
decreased body fat and increased mineral content in the bones
compared to wild-type mice. These differences are intensified
with age with the consequence that mice have an increased
lifespan in the absence of CD14, independent of the genetic back-
ground. Accordingly, CD14-deficient mice do not become obese
on a high-fat diet and do not develop obesity-related patholo-
gies such as insulin resistance and cardiovascular complications
(Roncon-Albuquerque et al., 2008); these phenomena are CD14-
dependent but TLR4-independent. On a high-fat diet, CD14
expressed on both hematopoietic cells and adipocytes contributes
to mesenteric fat accumulation and type-2 diabetes development
(Fernandez-Real et al., 2011).
The mechanism through which CD14 participates in the reg-
ulation of lipogenesis, adipose tissue inflammation, and insulin
resistance is not known. One possibility is that unknown endoge-
nous ligands activate a CD14-dependent pathway leading to the
production of key factors for lipid accumulation. Otherwise,
CD14 may influence the intestinal flora composition with a con-
sequent effect on food absorbance and weight gain. This is an
attractive hypothesis. High amounts of soluble CD14 used to
compete with membrane CD14 were proven to be effective in
reducing adipocyte-mediated inflammation and insulin resis-
tance but ineffective in reducing body weight (Fernandez-Real
et al., 2011). Therefore, only the obesity-associated pathologies
could be corrected by soluble CD14 but not obesity itself. This
is consistent with the hypothesis that, if the intestinal flora is
altered in CD14-deficient mice, an acute treatment with soluble
CD14 could not restore the intestinal flora composition. Another
interesting possibility is that LPS could be the cause of CD14
activation, lipogenesis, obesity-driven inflammation, and insulin
resistance. This last hypothesis is presumably the most probable
one. Although there is no direct evidence that LPS can induce
obesity via the activation of a CD14-dependent pathway, indirect
observations strongly support this assumption: (i) in humans,
triglyceride-rich lipoproteins contain LPS that in normal condi-
tions is probably efficiently sequestered by soluble CD14; (ii) LPS
serum levels largely increase in high-fat diet; and (iii) increased
LPS levels are sufficient per se to predispose to obesity, insulin
resistance, and type-2 diabetes (Cani et al., 2007). Interestingly,
NFATc2/c4-deficient mice are resistant to high-fat-diet-induced
obesity, indicating that the activation of the NFAT signaling path-
way is absolutely required for fat accumulation (Yang et al., 2006).
Given the capacity of CD14 to initiate the NFAT pathway, this
observation calls for an evaluation of the role of the CD14/NFAT
signaling pathway in the control of obesity and insulin resis-
tance once induced by LPS in hematopoietic cells and/or in
non-hematopoietic cells including adipocytes. It would be inter-
esting to understand whether the CD14-initiated NFAT signaling
pathway regulates the production of key factors controlling lipid
accumulation.
CONCLUDING REMARKS
CD14, one of the first identified PRRs, plays multiple roles in
microbial recognition and signaling. It helps recognition of lig-
ands for TLR1, 2, 3, 4, 6, 7, and 9, and it contributes in at
least three different ways to the initiation of the signaling path-
ways activated in response to LPS: CD14 facilitates LPS recogni-
tion and the initiation of the MyD88-dependent pathway from
the cell membrane; it is required for the LPS receptor com-
plex re-localization in the endosome and the activation of the
TRIF-dependent pathway; it starts the calcium/NFAT pathway.
While it is indubitable that CD14 participates in the acti-
vation of multiple signaling pathways in response to microbial
stimuli, its role in host defense is not always protective, as pre-
viously outlined. Moreover, a curious negative role of CD14
in lipid accumulation, obesity, insulin resistance, and type-2
diabetes has been documented. Nevertheless, from an evolu-
tionary point of view, although adipocyte differentiation and
lipid accumulation with high efficiency may be detrimental in
conditions of high food availability, they could represent an
important survival advantage in conditions of limited alimen-
tary resources. Therefore, the real evolutionary advantage pro-
vided by CD14 could have been related not only to innate
immunity and the protection against specific infectious agents
but also to metabolism by facilitating the generation of energy
stores.
Many fundamental questions remain unsolved. These ques-
tions include: (i) how CD14 initiates the NFAT signaling pathway
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and mediates the endosomal TLR4 re-localization in response
to LPS; (ii) how CD14 contributes to host protection or, vice-
versa, is deleterious depending on the type of infection; (iii) how
CD14 and possibly the CD14/NFAT pathway regulate metabolism
and lipid accumulation; (iv) what is the role of CD14 expressed
by non-hematopoietic cells? Understanding these fundamental
questions would give an important contribution to the def-
inition of the basic mechanisms of innate immunity and to
the comprehension of the link between the immune and the
endocrine systems.
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